Livedoid vasculitis
Livedoid vasculitis د پوستکي اوږدمهاله ناروغي ده چې په عمده توګه په ځوانو او منځني عمر لرونکو میرمنو کې لیدل کیږي. یو لنډیز چې د دې ځانګړتیاو تشریح کولو لپاره کارول کیږي د "د ټیټو پښو د جالیو نمونو سره دردناک purpuric زخمونه" (جامني). دا د یو شمیر ناروغیو سره تړاو لري، په شمول د اوږدمهاله وینس لوړ فشار او ویروسونه.
☆ د آلمان څخه د 2022 سټیفټنګ وارینسټ پایلو کې ، د ماډلډرم سره د مصرف کونکي رضایت د تادیه شوي ټیلی میډیسن مشورې په پرتله یوازې یو څه ټیټ و.
دا د درد سره کیدی شي.
References
Livedoid vasculopathy د پوستکي یو نادر حالت دی چې د دردناک زخمونو لخوا مشخص شوی چې په ټیټ پښو کې بیرته راځي.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy د پوستکي یو نادر حالت دی چې په ټیټو پښو کې د تکراري زخمونو لامل کیږي او د پوټکي داغونه پریږدي چې د ایټروفي بلانچ په نوم پیژندل کیږي. پداسې حال کې چې دقیق علت لا تر اوسه روښانه نه دی، داسې انګیرل کیږي چې د وینې د ټوټو زیاتوالی (hypercoagulability) اصلي عامل دی، چې التهاب ثانوي رول لوبوي. هغه فکتورونه چې د کلټینګ سره مرسته کوي په لاندې ډول دي - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. په بایوپسي کې، حالت د رګونو دننه د وینې ټوټې، د رګونو دیوالونو ضخامت، او داغونه ښیې. درملنه کې یو څو اړخیزه طریقه شامله ده چې د درملو په څیر د پلیټلیټ ضد درملو، د وینې کمولو، او فایبرینولوټیک درملنې سره د وینې د ټوټو په مخنیوي تمرکز کوي. د دې پوستکي حالت لپاره مختلف درمل کارول کیدی شي - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy یو نادر حالت دی چې په دواړو پښو کې زخمونه واقع کیږي. داسې انګیرل کیږي چې د وینې په کوچنیو رګونو کې د وینې ټوټو رامینځته کیدل د رګونو استر ته د زیان رسولو سربیره ، د وینې د ټوټې کیدو د زیاتوالي او د ټوټې ټوټې کیدو کمیدو له امله رامینځته کیږي. دا په میرمنو کې ډیر عام دی، په ځانګړې توګه د 15 او 50 کلونو ترمنځ. د سګرټ څکولو پریښودل، د زخمونو ساتنه، او د وینی کمولو او د انټي پلیټینټ درملو په څیر د درملو کارول اغیزمن دي.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
